Navigation Links
Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption
Date:4/27/2009

LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Pomegranate juice may slow the progression of post-treatment prostate cancer recurrence, according to new long-term research results being presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA). Researchers found that men who have undergone treatment for localized prostate cancer could benefit from drinking pomegranate juice.

The two-stage clinical trial followed a total of 48 participants over six years. Eligible participants had a rising PSA after surgery or radiotherapy, a PSA greater than 0.2 ng/ml and less than 5 ng/ml and a Gleason score of 7 or less. These patients were treated by drinking eight ounces of pomegranate juice daily. Currently, in the sixth year of treatment, active patients who remain on the study have a median total follow-up of 56 months. These participants continue to experience a significant increase in PSA doubling time following treatment, from a mean of 15.4 months at baseline to 60 months post-treatment, with a median PSA slope decrease of 60 percent, 0.06 to 0.024.

Researchers compared active patients, who remain on the study, with non-active patients, who no longer remain on the study. Though these two groups demonstrated similar mean PSA doubling times at baseline, both the PSA doubling time prolongation and the decline in median PSA slope were greater in active patients when compared to non-active patients.

"This study suggests that pomegranate juice may effectively slow the progression of prostate cancer after unsuccessful treatment," said Christopher Amling, MD, an AUA spokesman. "This finding and other ongoing research might one day reveal that pomegranate juice is an effective prostate cancer preventative agent as well."

Parts of this ongoing study suggest that some patients may be more sensitive to the effects of pomegranate juice on PSA doubling time. Pha
'/>"/>

SOURCE American Urological Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. First Swiss Patients Treated with the Percutaneous MitraClip(R) System
2. New Proton Therapy Equipment Enables More Tumors to be Treated
3. New Research Suggests Platelet Stickiness May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease
4. Cardiac Disease in Women Remains Untreated for Decades
5. Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
6. Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients
7. Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients
8. Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System
9. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
10. American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression
11. First European Patients Treated With the Percutaneous MitraClip(R) System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , SAN DIEGO, Nov. 25 /PRNewswire-FirstCa...device company focused on developing products for ...pine, announced today that it will host a conferen... ET / 2:30 p.m. PT. The conference call will focu...the Company,s products and will include comments f...
(Date:11/25/2009)... , FRAMINGHAM, Mass. and SYDNEY, Nov. 25 /PRNew...(Nasdaq: HTWR ; ASX: HIN), a leading innovator an...ory support technologies revolutionizing the treat...at it is scheduled to make an investor presentatio...ference at 8:00 am EST on Wednesday, December 2, 2...
(Date:11/24/2009)... , MADISON, N.J., Nov. 24 /PRNewswire-FirstCal...), the world,s leading provider of diagnostic test...s scheduled to speak at the 21st Annual Piper Jaff...resentation is scheduled for Wednesday, December 2... conference, the company will reaffirm its 2009 gu...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Details Emerge About Approach Results of First US Face Transplant 57822 1Details Emerge About Approach Results of First US Face Transplant 57822 2Hidden Valley 28R 29 Announces Fourth Annual Love Your Veggies 28TM 29 School Grant Program 57817 1Hidden Valley 28R 29 Announces Fourth Annual Love Your Veggies 28TM 29 School Grant Program 57817 2Hidden Valley 28R 29 Announces Fourth Annual Love Your Veggies 28TM 29 School Grant Program 57817 3Hidden Valley 28R 29 Announces Fourth Annual Love Your Veggies 28TM 29 School Grant Program 57817 4Dr Robert Lanza Featured on Michio Kakus Explorations in Science 14184 1Dr Robert Lanza Featured on Michio Kakus Explorations in Science 14184 2Dr Robert Lanza Featured on Michio Kakus Explorations in Science 14184 3
...Innovations and a Health Conscious,Public?, WASHIN...e Food,and Drug Administration (FDA) must adapt to...althcare, Commissioner Andrew von,Eschenbach told ...h,Annual Conference April 12 in Bethesda, Md. , FD...mited,financial and personnel resources to deal wi...
... Giaconda Ltd (ASX: GIA) today,announced that the ... the Company,s Investigational New Drug applicatio...to treat patients with,Crohn,s Disease infected wi... , ,The Company understands that its lead product,...o the FDA for this indication. There,are no anti-M...
Other Medicine Technology:FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,FDA Regulations 2FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4
(Date:11/27/2009)...Newswire-USNewswire/ -- Considered a highly risky ...ago, solid organ transplantation is now a life-sav...ry men and women who gathered at the Winspear Oper...r from medical centers around the world to celebra...ant Institute (BRTI), one of the pioneers of solid...
(Date:11/27/2009)...are Holdings has announced that it has become a na... the largest nonprofit organizations dedicated to ... Delray Beach, FL (Vocus) ...B: XCHO), a company specializing in the marketing ...ducts, has announced today that is has become a na...
(Date:11/27/2009)...-purpose bilingual coloring books designed for chi...ss community to educate - inform parents and child...ues to Dinosuars to ABC,S and a host of other topi...WEB) November 27, 2009 -- Today’s children h...em busy any hour of the day, but one of the oldest...
(Date:11/26/2009)...ber of Americans living with diabetes will nearly ....1 million in 2034. Over the same period, spending...billion to $336 billion, even with no increase in ...e University of Chicago report in the December iss...h diabetes covered by Medicare will rise from 8.2 ...
(Date:11/26/2009)...avid Kim of the Live Life Again Center, a practice...of a growing number of physicians who are taking ...nnect with individuals who are interested in surgi... Dr. Kim is utilizing Facebook to share before-and...ith the community. , Dall...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...s surgery for morbid obesity have increased risk f...ding to a paper being presented at the American So...ntific Exposition in San Diego. 'Gastric bypa...of Mayo Clinic College of Medicine in Rochester, M...
... pyres began Friday here to ward off dengue and pr...edic hymns by Hindu priests from across the countr...e ritual was performed with the lighting of a larg...off dengue, malaria and other diseases. The organi...
...rtually crippled Saturday as over 300 doctors went...tack on one of them //by relatives of a patient wh...ent doctors-the mainstay in any medical institutio...med the emergency ward and thrashed the doctor all...
...nic attacks are less likely to have properly manag...ications //and poorer quality of life, a new study...researcher with Group Health Cooperative in Seattl...'But because panic and depression so often go hand...
...for the treatment of breast cancers in the early s...ial // specifically in treating breast cancer in w...romatase inhibitor that works by inhibiting the oe...so intend to introduce this drug into the market b...
... to Primary Education (commonly known as Mid-Day M...l programme in the world //covering nearly 12 cror...Education Guarantee Scheme (EGS)/Alternative and I...vised in June 2006 to ensure provision of mid day ...
Other Medicine News:Health News:Gastric Bypass Surgery May Lead to Increased Kidney Stone Risk 2Health News:Panic Attacks Can Increase Complications in Diabetes Patients 2Health News:Mid-Day Meal Scheme Catches on in India 2
BLF21D Dual Channel
Oxyflo 4000
Embo Dop
Multi Dop T1
Medicine Products: